Teva launches campaign for COVID caregivers To view this email as a web page,
click here AstraZeneca COVID-19 vaccine linked to rare blood clots, EMA official says, but benefits still outweigh risks Verizon jumps into virtual care market with BlueJeans Telehealth Teva joins pharma's help-the-helpers trend with campaign for Canada's COVID caregivers Mastercard makes healthcare move with digital ID solution patients can use on their smartphones AstraZeneca, MGH test virtual health platform to keep prescribing up—even when in-person doc visits are down In California, Blue Shield's vaccination takeover fixes what wasn't broken COVID-19 tracker: EMA to reveal AZ vaccine blood clot findings; Pharma R&D budgets soared in 2020 Novavax adds blinded crossover arms to COVID-19 vaccine trials Featured Story | By Eric Sagonowsky AstraZeneca’s COVID-19 vaccine rollout has spurred concerns over blood clots in Europe, but after an urgent review, the bloc's top drug regulator offered fresh backing last month. Now, a European Medicines Agency official says the vaccine is linked to rare blood clots, but that the benefits of vaccination still outweigh the risks. read more |
| |
|---|
|
Top Stories By Heather Landi Following its acquisition of video conferencing platform BlueJeans last year, Verizon has built out a telehealth platform for providers. With the launch of BlueJeans Telehealth, the telecommunications giant is looking to get a slice of the rapidly growing virtual care technology market. read more By Beth Snyder Bulik Teva Canada wants to lessen COVID caregiver stress, and today launches a raft of new resources and programs to support their mental health. The effort includes virtual life coaching sessions and free access to a caregiver support app, along with caregivers' stories and advice. read more By Heather Landi In its first major move into healthcare, Mastercard is teaming up with b.well Connected Health to launch a digital solution for patient identification that works on smartphones. The digital ID verification service uses smart biometrics and other technology to give patients a simpler and more secure way to prove their identity when accessing their health records. read more By Conor Hale The goal is to establish and validate the Big Pharma’s recently launched digital health platform designed around patients with chronic illnesses, to help them manage their conditions without stepping foot into the academic medical center’s clinic. read more By Rachel Bluth, Kaiser Health News What’s happening in California’s Mendocino County echoes the frustrations, successes and stumbles felt by counties and clinics across the state during this turbulent transition. read more By Kevin Dunleavy,Fraiser Kansteiner,Eric Sagonowsky The European Medicines Agency will report its findings on rare cases of blood clots in AstraZeneca vaccine recipients. A look at Pharma's top 10 R&D spenders revealed that investment soared in response to the pandemic. Teva Canada has launched a program to help caregivers deal with the stress brought on by the pandemic. Ortho will increase production of its COVID tests by more than threefold. And more headlines. read more By Nick Paul Taylor Novavax has added crossover arms to late-phase clinical trials of its COVID-19 vaccine. The action will enable participants in the placebo cohorts of the original trials to get vaccinated without unblinding the studies. read more |
|
